In Liqwd, Inc. v. L’Oreal USA, Inc., the Federal Circuit vacated a decision of the USPTO Patent Trial and Appeal Board (PTAB) that failed to take into account evidence of copying in its obviousness analysis. The Federal...more
In the latest dispute surrounding the “patent dance” provisions of the Biologics Price Competition and Innovation Act (BPCIA), Genentech, Inc. has filed a complaint against Amgen, Inc., alleging that after opting into the...more
2/24/2017
/ aBLA ,
Biologics ,
Biosimilars ,
BPCIA ,
Confidential Information ,
Food and Drug Administration (FDA) ,
Generic Drugs ,
Injunctive Relief ,
Motion to Compel ,
Patent Dance ,
Patent Infringement ,
Pharmaceutical Patents